Drug for rare disease could be used to extend lives of ovarian cancer patients, study finds

A drug typically used for a rare disorder could extend the lives of patients battling a form of ovarian cancer, a study has found.

Women diagnosed with platinum-resistant ovarian cancer, a type where the disease progresses within six months of platinum-based chemotherapy, often only live for about a year post-diagnosis.